Gamida Cell - Cord Blood Transplant

Press Releases - 2012

First Pediatric Sickle Cell Disease Patient Receives NiCord® Stem Cell Transplantation in Gamida Cell Pilot Study at Duke University
Nov. 12, 2012

Gamida Cell Completes Enrollment for Phase I/II Study of Second Pipeline Product Nicord® For Hematological Malignancies
Sep. 19, 2012

Gamida Cell Closes $10 Million E Financing Round Earmarked to Support the Global Commercialization of the Company’s Lead Product StemEx® for Leukemia and Lymphoma
May. 15, 2012

The Gamida Cell-Teva Joint Venture Concludes Enrollment for the Phase III Study of StemEx®, a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
Feb. 13, 2012

Press Releases Archive

Recent
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003

To learn more about our products and clinical trials, please fill in:
Name: 
Email: 
Country: 
* Message: